|
COURSE TITLE
|
SUBCATEGORY |
CQR CREDITS |
EXP DATE |
| The Radiographer: Patient Education and Communication |
Patient Interactions and Management |
1.00 |
4/1/2024 |
| Patient-Centered Breast Imaging and Specialized Treatment |
Patient Interactions and Management |
0.75 |
1/1/2024 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update |
Patient Interactions and Management |
1.00 |
10/1/2023 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update |
Radiation Physics, Radiobiology, and Regulations |
0.25 |
10/1/2023 |
| Ethical Issues in Breast Cancer Screening |
Patient Interactions and Management |
0.25 |
9/1/2023 |
| Imaging Findings and Patient Management in HIV-Associated Malignancies |
Endocrine and Oncology Procedures |
1.00 |
9/1/2023 |
| Breast Cancer: The Role of Functional Molecular Imaging |
Endocrine and Oncology Procedures |
0.75 |
6/1/2023 |
| PET and PET/CT in the Diagnosis and Management of Follicular Lymphoma |
Endocrine and Oncology Procedures |
1.00 |
4/1/2023 |
| The Role of Digital Radiography, Computed Tomography, Ultrasound, and Magnetic Resonance Imaging in the Diagnosis of Intimate Partner Violence |
Patient Interactions and Management |
0.50 |
2/1/2023 |
| The Evolving Role of Magnetic Resonance Imaging in Parkinson’s Disease and Atypical Parkinsonism Disorders |
Patient Interactions and Management |
0.50 |
1/1/2023 |
| Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health |
Other Imaging Procedures |
1.50 |
11/1/2022 |
| Brachytherapy and Breast Cancer: Best Practices in Imaging-Based Patient Selection, Treatment Planning, and Future Trends |
Patient Interactions and Management |
0.50 |
8/1/2022 |
| Radiation Exposure and Cancer Risk |
Radiation Physics, Radiobiology, and Reguations |
1.00 |
8/1/2022 |
| Positron Emission Tomography in the Diagnosis and Treatment of Rheumatoid Arthritis |
Other Imaging Procedures |
1.00 |
7/1/2022 |
| Three-Dimensional Digital Breast Tomosynthesis: An Update |
Patient Interactions and Management |
0.50 |
7/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography |
Endocrine and Oncology Procedures |
0.25 |
4/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography |
Patient Interactions and Management |
0.50 |
4/1/2022 |
| Surgeon General's Workshop on Improving Health Literacy |
Patient Interactions and Management |
3.00 |
3/1/2022 |
| The Role of Theranostics in Nuclear Medicine: Cancer Diagnosis and Management |
Endocrine and Oncology Procedures |
1.00 |
12/1/2021 |
| Hepatobiliary Scintigraphy for the Diagnosis of Acute Cholecystitis |
Gastrointestinal and Genitourinary Procedures |
1.00 |
7/1/2021 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer |
Endocrine and Oncology Procedures |
0.50 |
3/1/2024 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer |
Radionuclides and Radiopharmaceuticals |
0.50 |
3/1/2024 |
| Examining the Role of High-Resolution Breast PET in the Screening, Diagnosis, and Management of Breast Cancer |
Endocrine and Oncology Procedures |
1.25 |
2/1/2024 |
| Imaging Insights in Alzheimer's Disease |
Other Imaging Procedures |
0.50 |
12/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging |
Instrumentation |
0.50 |
9/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging |
Radiation Physics, Radiobiology, and Regulations |
0.50 |
9/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging |
Radionuclides and Radiopharmaceuticals |
0.25 |
9/1/2023 |
| Imaging and Ethical Considerations for Geriatric Patients |
Patient Interactions and Management |
1.00 |
6/1/2023 |
| Lung Cancer: The Role of Nuclear Imaging With 18F-FDG PET/CT |
Endocrine and Oncology Procedures |
0.50 |
12/1/2022 |
| Lung Cancer: The Role of Nuclear Imaging With 18F-FDG PET/CT |
Instrumentation |
0.50 |
12/1/2022 |
| Informed Decision Making and Consent: Principles and Applications |
Patient Interactions and Management |
1.00 |
11/1/2022 |
| Utilizing Gastrointestinal Sonography to Reduce Ionizing Radiation Within a Pediatric Population |
Patient Interactions and Management |
0.50 |
10/1/2022 |
| Managing a Multigenerational Team of Imaging Professionals to Enhance Patient Care |
Patient Interactions and Management |
1.25 |
10/1/2022 |
| PET/CT: Optimizing Imaging Protocols to Reduce Radiation Exposure |
Instrumentation |
0.50 |
8/1/2022 |
| PET/CT: Optimizing Imaging Protocols to Reduce Radiation Exposure |
Radiation Physics, Radiobiology, and Regulations |
0.50 |
8/1/2022 |
| Current Perspectives and Future Directions in PET and Treatment Planning for Breast Imaging |
Endocrine and Oncology Procedures |
0.50 |
2/1/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers |
Endocrine and Oncology Procedures |
0.75 |
11/1/2021 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers |
Instrumentation |
0.25 |
11/1/2021 |
| Fusion Imaging in Breast Cancer: Usefulness and Limitations with PET and CT |
Endocrine and Oncology Procedures |
0.50 |
9/1/2021 |
| Myocardial Perfusion Imaging: Protocols, Radiotracers and Imaging Systems to Reduce Radiation Exposure |
Cardiac Procedures |
0.50 |
7/1/2021 |
| Myocardial Perfusion Imaging: Protocols, Radiotracers and Imaging Systems to Reduce Radiation Exposure |
Instrumentation |
0.50 |
7/1/2021 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL |
Endocrine and Oncology Procedures |
0.25 |
2/4/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL |
Radiation Physics, Radiobiology, and Reguations |
0.25 |
2/4/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL |
Radionuclides and Radiopharmaceuticals |
0.25 |
2/4/2022 |
| A Review of MRI of the Breast and MRI-Guided Stereotactic Biopsy |
Patient Interactions and Management |
0.50 |
5/7/2021 |
| Screening for Breast Cancer: A New Approach |
Patient Interactions and Management |
0.50 |
5/6/2021 |
| The Role of Image Fusion in Medical Dosimetry |
Instrumentation |
1.00 |
5/6/2021 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer |
Endocrine and Oncology Procedures |
0.75 |
5/6/2021 |
| Image-Guided Radiation Therapy for Breast Cancer |
Patient Interactions and Management |
0.50 |
5/6/2021 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain |
Endocrine and Oncology Procedures |
0.75 |
4/26/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain |
Patient Interactions and Management |
0.25 |
4/26/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer |
Endocrine and Oncology Procedures |
0.25 |
11/5/2021 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer |
Patient Interactions and Management |
0.50 |
11/5/2021 |
984.227.8560